|
PVCT Provectus Biopharmaceuticals Inc 315545 |
| Income Statement |
|
Revenue
|
form10-q
|
109,745 |
|
Net Income
|
form10-q
|
-1,014,351 |
|
Profit Margin
|
|
-924.28% |
| Balance Sheet |
|
Current Assets
|
760,003 |
|
Assets
|
802,033 |
|
Current Liabilities
|
6,224,763 |
|
Liabilities
|
6,224,763 |
|
Equity
|
-5,422,730 |
|
Shares Out
|
419,907,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-2,372,083 |
| Market Analysis |
Market Cap
|
37,500,511 |
|
Price
|
0.11 |
|
BVPS
|
1.08 |
|
PB
|
0.11 |
|
EPS
|
-0.01 |
|
PS
|
85.43 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PVCT documents filed with the SEC.
PVCT Filings
Clear
